International Conference on Retroviruses and Novel Drugs June 08-09, 2015 Chicago, Illinois, USA

OMICS Group International is currently organizing International Conference on Retroviruses & Novel drugs (Retroviruses-2015) during June 08^th-09^th, 2015, Chicago, Illinois, USA with a theme “Current concepts in Retroviruses & Advanced drug research”. Chicago is having 6 major universities, 9 societies which are working on the field. USA is having 7 major companies which are producing antiretroviral drugs.

Retroviruses-2015 is anticipating participation from renowned speakers including researchers, basic scientists and clinicians, and many from leading universities, companies and virology research institutions, hospitals sharing their novel researches in the arena of Retroviruses and Novel Drugs. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies.

OMICS Group International has been associated with more than 700 scientific Societies and Associations. OMICS Group refereed journals were well established with more than 30000 Editorial board members. These journals were dedicated to provide significant services for more than 3.5 million readers across the globe.

According to the recent reports, the prevalence of HIV drug resistance has been around 7% between the years 2003 and 2010 worldwide. With the expansion of Anti retroviral therapy (ART) coverage achieved over the recent years, increasing prevalence of HIV drug resistance has been reported, particularly to Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI). Reports suggest that 10-17% of naïve HIV patients in Australia, Japan, United States and Europe are infected with resistant viral strains to at least one of the ART agents. At the end of 2008, an estimated 1,178,350 persons aged ≥13 years were living with HIV infection, including 236,400 (20.1%) whose infections had not been diagnosed in USA.For more